Radioactively labelled Nbs have been developed for the detection of not only other cancer biomarkers, such as EGFR and fibronectin, but also different diseases such as atherosclerosis—indicating that Nbs have a promising future in the field of in vivo diagnostic methods [117,118,119,120]. Here, EGFR is linked to cancer.